-
61
-
62
Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics
Published 2025-02-01Subjects: Get full text
Article -
63
Gastroesophageal reflux disease (<i>Proceedings of the Seventeenth Russian Gastroenterological Week, October 10–12 2011, Moscow</i>)
Published 2012-09-01Subjects: Get full text
Article -
64
Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
Published 2014-09-01Subjects: Get full text
Article -
65
-
66
-
67
COVID-19: Impact in endothelial function and therapy with Mesenchymal Stromal Cells
Published 2021-12-01Subjects: Get full text
Article -
68
COVID-19: Impact in endothelial function and therapy with Mesenchymal Stromal Cells
Published 2021-12-01Subjects: Get full text
Article -
69
-
70
Doves, Diplomats, and Diabetes : a Darwinian interpretation of type 2 diabetes and related disorders /
Published 2013Subjects: “…Diabetes Pathogenesis. 7645…”
View in OPAC
Book -
71
<i>H. pylori</i>-negative peptic ulcer: state-of-the-art
Published 2014-07-01Subjects: Get full text
Article -
72
-
73
-
74
Pathogenic role of lipids in non-alcoholic fatty liver disease
Published 2012-02-01Subjects: Get full text
Article -
75
Structural and Functional Fundamentals of Alcoholic Disease
Published 2018-11-01Subjects: Get full text
Article -
76
-
77
-
78
Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
Published 2022-01-01“…A limited remediation in most common functional GI diseases, functional dyspepsia (FD) and irritable bowel syndrome (IBS), is conditioned by their multifactorial pathogenesis. Meanwhile, most specific medicines only target selected pathogenesis components, thus warranting a multitarget agent development. …”
Get full text
Article -
79
Distinguishing rheumatoid arthritis from psoriatic arthritis
Published 2018-08-01“…Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) have key differences in clinical presentation, radiographic findings, comorbidities and pathogenesis to distinguish between these common forms of chronic inflammatory arthritis. …”
Get full text
Article -
80
Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease
Published 2025-02-01“…Abstract RelA, also known as nuclear factor kappa B p65, plays a crucial role in the pathogenesis of various liver diseases. However, the specific role of RelA in hepatocytes during the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) is not well understood. …”
Get full text
Article